J. Lizón

Phase II randomised trial of raltitrexed–oxaliplatin vs raltitrexed–irinotecan as first-line treatment in advanced colorectal cancer

Jaime Feliú, C. Castañón, Antonieta Salud et al. · British Journal of Cancer · 2005 · 36 citations · Full text

Medicine, Oncology, Pharmacology +14

Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin–gemcitabine–vinorelbine. A phase II study

Jaime Feliú, J. Lizón, José Ignacio Chacón et al. · Annals of Oncology · 2001 · 24 citations · Full text

Medicine, Oncology, Pharmacology +12

Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer

Enrique Espinosa, Serafín Morales, Pablo Borrega et al. · Cancer Chemotherapy and Pharmacology · 2004 · 23 citations

Medicine, Oncology, Pharmacology +11

Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study

Serafín Morales, Antonio Lorenzo, Manuel Ramos et al. · Cancer Chemotherapy and Pharmacology · 2003 · 23 citations

Medicine, Oncology, Pharmacology +12

Treatment of Advanced Colorectal Cancer with Recombinant Interferon Alpha and Fluorouracil: Activity in Liver Metastasis

José Jimeno, Carlos Camps, Enrique Aranda et al. · Cancer Investigation · 1992 · 22 citations

Medicine, Oncology, Pharmacology +17